If NAD injections are still something you want to explore after that, approach them as an emerging therapynot a proven shortcut to younger cells
Mysimba (Naltrexone/Bupropion) A daily tablet that acts on the brains reward system to reduce cravings and help manage emotional eating
The amino acid sequence of BPC-157 is as follows: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val This sequence represents the order in which the 15 amino acids are linked together to form the BPC-157 peptide
July 2026 (Correction) Corrected two statements that described GHK-Cu at 340.4 daltons as sitting above the 500-dalton passive penetration ceiling
Unlike corticosteroid injections (which reduce pain short-term but damage cartilage long-term), BPC-157 appears to be cartilage-sparing and potentially cartilage-supportive making it relevant for early-stage osteoarthritis or post-injury joint degradation
The tirzepatide comparison is relevant because: It shares GIP and GLP-1 agonism with retatrutide (but lacks glucagon agonism) It has actual FDA approval and established safety profiles Anecdotal reports of cagrilintide-tirzepatide combinations exist in clinical practice The dual agonist mechanism is less complex than retatrutide's triple agonism For those researching metabolic peptides, understanding the distinctions between different compound classes helps inform evidence-based decision-making